Treatment Outcomes in Patients with Advanced Fibrolamellar Hepatocellular Carcinoma Under Systemic Treatment: Analysis of Clinical Characteristics, Management, and Radiomics

PURPOSE: Fibrolamellar hepatocellular carcinoma (FLHCC) is a rare primary liver malignancy often diagnosed at advanced stages. While there are limited data on the efficacy of specific agents, we aim to report outcomes of patients treated with systemic therapies and explore prognostic factors. PATIEN...

Descripción completa

Detalles Bibliográficos
Autores principales: Da Fonseca, Leonardo G, Yamamoto, Victor Junji, Trinconi Cunha, Mateus, Torre, Giovanna Sawaya, Araujo, Raphael L C, Fonseca, Gilton Marques, Chen, Andre Tsin Chih, Chagas, Aline Lopes, Herman, Paulo, Alves, Venancio Avancini Ferreira, Carrilho, Flair Jose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625783/
https://www.ncbi.nlm.nih.gov/pubmed/37933267
http://dx.doi.org/10.2147/JHC.S428741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625783/
https://www.ncbi.nlm.nih.gov/pubmed/37933267
http://dx.doi.org/10.2147/JHC.S428741

Ejemplares similares